455 related articles for article (PubMed ID: 17229678)
1. Nephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2.
Shi PP; Cao XR; Qu J; Volk KA; Kirby P; Williamson RA; Stokes JB; Yang B
Am J Physiol Renal Physiol; 2007 May; 292(5):F1334-44. PubMed ID: 17229678
[TBL] [Abstract][Full Text] [Related]
2. Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion.
Yang B; Zhao D; Qian L; Verkman AS
Am J Physiol Renal Physiol; 2006 Aug; 291(2):F465-72. PubMed ID: 16434568
[TBL] [Abstract][Full Text] [Related]
3. p.R254Q mutation in the aquaporin-2 water channel causing dominant nephrogenic diabetes insipidus is due to a lack of arginine vasopressin-induced phosphorylation.
Savelkoul PJ; De Mattia F; Li Y; Kamsteeg EJ; Konings IB; van der Sluijs P; Deen PM
Hum Mutat; 2009 Oct; 30(10):E891-903. PubMed ID: 19585583
[TBL] [Abstract][Full Text] [Related]
4. Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus.
de Mattia F; Savelkoul PJ; Kamsteeg EJ; Konings IB; van der Sluijs P; Mallmann R; Oksche A; Deen PM
J Am Soc Nephrol; 2005 Oct; 16(10):2872-80. PubMed ID: 16120822
[TBL] [Abstract][Full Text] [Related]
5. Integrin-linked kinase regulates tubular aquaporin-2 content and intracellular location: a link between the extracellular matrix and water reabsorption.
Cano-Peñalver JL; Griera M; Serrano I; Rodríguez-Puyol D; Dedhar S; de Frutos S; Rodríguez-Puyol M
FASEB J; 2014 Aug; 28(8):3645-59. PubMed ID: 24784577
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation.
Sohara E; Rai T; Yang SS; Uchida K; Nitta K; Horita S; Ohno M; Harada A; Sasaki S; Uchida S
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14217-22. PubMed ID: 16968783
[TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus.
Petrillo F; Chernyakov D; Esteva-Font C; Poulsen SB; Edemir B; Fenton RA
FASEB J; 2022 Nov; 36(11):e22583. PubMed ID: 36197017
[TBL] [Abstract][Full Text] [Related]
8. Loss of calcineurin Aalpha results in altered trafficking of AQP2 and in nephrogenic diabetes insipidus.
Gooch JL; Guler RL; Barnes JL; Toro JJ
J Cell Sci; 2006 Jun; 119(Pt 12):2468-76. PubMed ID: 16735444
[TBL] [Abstract][Full Text] [Related]
9. Aquaporin 2 mutations in nephrogenic diabetes insipidus.
Loonen AJ; Knoers NV; van Os CH; Deen PM
Semin Nephrol; 2008 May; 28(3):252-65. PubMed ID: 18519086
[TBL] [Abstract][Full Text] [Related]
10. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
Zhang Y; Peti-Peterdi J; Müller CE; Carlson NG; Baqi Y; Strasburg DL; Heiney KM; Villanueva K; Kohan DE; Kishore BK
J Am Soc Nephrol; 2015 Dec; 26(12):2978-87. PubMed ID: 25855780
[TBL] [Abstract][Full Text] [Related]
11. Neonatal mortality in an aquaporin-2 knock-in mouse model of recessive nephrogenic diabetes insipidus.
Yang B; Gillespie A; Carlson EJ; Epstein CJ; Verkman AS
J Biol Chem; 2001 Jan; 276(4):2775-9. PubMed ID: 11035038
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of an aquaporin-2 mutation causing a severe form of nephrogenic diabetes insipidus.
Saglar Ozer E; Moeller HB; Karaduman T; Fenton RA; Mergen H
Cell Mol Life Sci; 2020 Mar; 77(5):953-962. PubMed ID: 31302751
[TBL] [Abstract][Full Text] [Related]
13. Aquaporin 2: from its discovery to molecular structure and medical implications.
Sasaki S
Mol Aspects Med; 2012; 33(5-6):535-46. PubMed ID: 23078817
[TBL] [Abstract][Full Text] [Related]
14. Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla.
Rieg T; Tang T; Murray F; Schroth J; Insel PA; Fenton RA; Hammond HK; Vallon V
J Am Soc Nephrol; 2010 Dec; 21(12):2059-68. PubMed ID: 20864687
[TBL] [Abstract][Full Text] [Related]
15. Heteroligomerization of an Aquaporin-2 mutant with wild-type Aquaporin-2 and their misrouting to late endosomes/lysosomes explains dominant nephrogenic diabetes insipidus.
Marr N; Bichet DG; Lonergan M; Arthus MF; Jeck N; Seyberth HW; Rosenthal W; van Os CH; Oksche A; Deen PM
Hum Mol Genet; 2002 Apr; 11(7):779-89. PubMed ID: 11929850
[TBL] [Abstract][Full Text] [Related]
16. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
Li Y; Shaw S; Kamsteeg EJ; Vandewalle A; Deen PM
J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
[TBL] [Abstract][Full Text] [Related]
17. Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation.
Yang B; Zhao D; Verkman AS
FASEB J; 2009 Feb; 23(2):503-12. PubMed ID: 18854434
[TBL] [Abstract][Full Text] [Related]
18. A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L.
de Mattia F; Savelkoul PJ; Bichet DG; Kamsteeg EJ; Konings IB; Marr N; Arthus MF; Lonergan M; van Os CH; van der Sluijs P; Robertson G; Deen PM
Hum Mol Genet; 2004 Dec; 13(24):3045-56. PubMed ID: 15509592
[TBL] [Abstract][Full Text] [Related]
19. Fluconazole Increases Osmotic Water Transport in Renal Collecting Duct through Effects on Aquaporin-2 Trafficking.
Vukićević T; Hinze C; Baltzer S; Himmerkus N; Quintanova C; Zühlke K; Compton F; Ahlborn R; Dema A; Eichhorst J; Wiesner B; Bleich M; Schmidt-Ott KM; Klussmann E
J Am Soc Nephrol; 2019 May; 30(5):795-810. PubMed ID: 30988011
[TBL] [Abstract][Full Text] [Related]
20. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
Boone M; Kortenoeven M; Robben JH; Deen PM
Nephrol Dial Transplant; 2010 Jan; 25(1):48-54. PubMed ID: 19666909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
